Publications by authors named "Colleen Fullenkamp"

Claim this Profile
P
PI3K regulates TAZ/YAP and mTORC1 axes that can be synergistically targeted.
Keith C Garcia, Ali A Khan, Krishnendu Ghosh, Souradip Sinha, Nicholas Scalora, Colleen Fullenkamp

bioRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
Nicole Merritt, Keith Garcia, Dushyandi Rajendran, Zhen-Yuan Lin, Xiaomeng Zhang, Colleen Fullenkamp

Elife· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive evaluation of Hippo pathway silencing in sarcomas.
Nicole M Merritt, Colleen A Fullenkamp, Sarah L Hall, Qining Qian, Chandni Desai

Oncotarget· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAZ and YAP are frequently activated oncoproteins in sarcomas.
Colleen A Fullenkamp, Sarah L Hall, Omar I Jaber, Brittany L Pakalniskis, Erica C Savage

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoid.
Kelly N Messingham, Heather M Holahan, Alexandra S Frydman, Colleen Fullenkamp, Rupasree Srikantha

PLoS One· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay.
Janet A Fairley, Matthew Bream, Colleen Fullenkamp, Sergei Syrbu, Mei Chen

J Am Acad Dermatol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK-cell receptor Ly49H.
Natalya V Guseva, Colleen A Fullenkamp, Paul W Naumann, Michael R Shey, Zuhair K Ballas

Eur J Immunol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squamous cell carcinoma cells differentially stimulate NK cell effector functions: the role of IL-18.
Mikel B Moore, Zoya B Kurago, Colleen A Fullenkamp, Charles T Lutz

Cancer Immunol Immunother· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis